Search - tctmd.com

Displaying 381 - 400 of 3172

Sort: Relevancy | Date

Presentation THT 2024

CardioDyme: A Compact Pump for Ambulatory ECMO

Presenter: Gopal K. Chopra

March 05, 2024

Presentation THT 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT 2024

Cardiogenic Shock in Stress Induced Cardiomyopathy Complicated by Left Ventricular Outflow Obstruction: Hemodynamic-Tailored Management

Presenter: Mary Quien

March 05, 2024

Presentation THT Abstracts 2024

Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock

Presenter: Kannu Bansal

March 04, 2024

Presentation THT Abstracts 2024

Impact of Cumulative Vasopressor and Inotrope Medications on Outcomes in Cardiogenic Shock: A Cardiogenic Shock Working Group Report

Presenter: Saraschandra Vallabhajosyula

March 04, 2024

Presentation THT Abstracts 2024

Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock

Presenter: McKenzie Sicke

March 04, 2024

Presentation THT Abstracts 2024

The Clinical Effectiveness of Pulmonary Artery Catheter in Patients with Cardiogenic Shock

Presenter: Atsuyuki Watanabe

March 04, 2024

Presentation THT Abstracts 2024

ImpellaÆ Use Improves Hemodynamics for Cardiogenic Shock from Ventricular Septal Defect (VSD)

Presenter: Brent Medoff

March 04, 2024

Presentation THT Abstracts 2024

Impact of Cardiogenic Shock Progression on Outcomes: SCAI B is Bad 2013 A Cardiogenic Shock Working Group Report

Presenter: Van-Khue Ton

March 04, 2024

Presentation THT Abstracts 2024

Temporal Trends of Vasopressor and Inotrope Use in Cardiogenic Shock: A Cardiogenic Shock Working Group Report

Presenter: Saraschandra Vallabhajosyula

March 04, 2024

Presentation THT Abstracts 2024

Clinical Presentation, Management, and Outcomes of Patients with Intermediate Risk Acute Pulmonary Embolism and Normotensive Shock.

Presenter: Robert Zilinyi

March 04, 2024

Presentation THT Abstracts 2024

Assessment of patients with cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation upgrade from Impella 5.5 univentricular support

Presenter: James Schurr

March 04, 2024

Presentation THT 2024

Cardiogenic Shock: The Case for Feasibility and Recovery

Presenter: Aasim Afzal

March 04, 2024

News Daily News

Salt Substitute Slashes New Hypertension Diagnoses: DECIDE-Salt

L.A. McKeown

February 14, 2024

Presentation Miami Valves 2024

Complete Coronary Revascularization: When and Why?

Presenter: Nikolaos Spilias

February 03, 2024

Presentation Miami Valves 2024

Optimizing Bifurcation LM PCI Strategy and Outcomes

Presenter: Yiannis S. Chatzizisis

February 03, 2024

Presentation Miami Valves 2024

Impella Assisted Bifurcation PCI of Severely Calcified Unprotected LM using RotaShock Technique

Presenter: Ruthvik Srinivasamurthy

February 03, 2024

Presentation Miami Valves 2024

Acute Myocardial Infarction Complicated with Cardiogenic Shock

Presenter: Miguel Martillo Correa

February 03, 2024

Presentation Miami Valves 2024

National Cardiogenic Shock Initiative: What we’ve learned?

Presenter: Alejandro Lemor

February 03, 2024

Presentation Miami Valves 2024

Contemporary management of AMI Shock in the Cath Lab – Evidence based Clinical Case?

Presenter: Carlos D. Davila

February 03, 2024

Advertisement

CardioDyme: A Compact Pump for Ambulatory ECMO

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Cardiogenic Shock in Stress Induced Cardiomyopathy Complicated by Left Ventricular Outflow Obstruction: Hemodynamic-Tailored Management

Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock

Impact of Cumulative Vasopressor and Inotrope Medications on Outcomes in Cardiogenic Shock: A Cardiogenic Shock Working Group Report

Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock

The Clinical Effectiveness of Pulmonary Artery Catheter in Patients with Cardiogenic Shock

ImpellaÆ Use Improves Hemodynamics for Cardiogenic Shock from Ventricular Septal Defect (VSD)

Impact of Cardiogenic Shock Progression on Outcomes: SCAI B is Bad 2013 A Cardiogenic Shock Working Group Report

Temporal Trends of Vasopressor and Inotrope Use in Cardiogenic Shock: A Cardiogenic Shock Working Group Report

Clinical Presentation, Management, and Outcomes of Patients with Intermediate Risk Acute Pulmonary Embolism and Normotensive Shock.

Assessment of patients with cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation upgrade from Impella 5.5 univentricular support

Cardiogenic Shock: The Case for Feasibility and Recovery

Salt Substitute Slashes New Hypertension Diagnoses: DECIDE-Salt

Complete Coronary Revascularization: When and Why?

Optimizing Bifurcation LM PCI Strategy and Outcomes

Impella Assisted Bifurcation PCI of Severely Calcified Unprotected LM using RotaShock Technique

Acute Myocardial Infarction Complicated with Cardiogenic Shock

National Cardiogenic Shock Initiative: What we’ve learned?

Contemporary management of AMI Shock in the Cath Lab – Evidence based Clinical Case?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content